4//SEC Filing
Accardi Mario Alberto 4
Accession 0001470831-25-000273
CIK 0001847903other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 7:56 PM ET
Size
8.9 KB
Accession
0001470831-25-000273
Insider Transaction Report
Form 4
Accardi Mario Alberto
President, Orexin Program
Transactions
- Sale
Ordinary Shares
2025-10-27$25.00/sh−8,000$200,000→ 194,394 total - Exercise/Conversion
Share Option (right to buy)
2025-10-27−5,000→ 30,000 totalExercise: $8.01Exp: 2034-02-01→ Ordinary Shares (5,000 underlying) - Exercise/Conversion
Ordinary Shares
2025-10-27$8.01/sh+5,000$40,050→ 202,394 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025.
- [F3]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 1, 2024.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0002074392
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 7:56 PM ET
- Size
- 8.9 KB